Evolving Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Results From a Survey Among US Cardiologists
Why the study?
What are the preferred antithrombotic strategies among US cardiologists for patients with atrial fibrillation undergoing percutaneous coronary intervention?
Population
US-based cardiologists serving as clinical investigators in academic sites and respondents to an online…
Design
Cross-sectional
Authors
Discussion
Loading...
Member takes
Implication
Diverse US cardiologist practices in AF-PCI antithrombotic regimens highlight interest in dropping aspirin; leaves optimal strategy open pending randomized trials.
Structured PICO
What are the preferred antithrombotic strategies among US cardiologists for patients with atrial fibrillation undergoing percutaneous coronary intervention?
P
Population
US-based cardiologists serving as clinical investigators in academic sites and respondents to an online question on cardiosource.org (n=194 total; 75 email survey responses, 119 online question responses)
I
Intervention
Survey regarding antithrombotic strategies in patients with atrial fibrillation needing stenting
O
Outcome
Variation in antithrombotic strategies (preferred stent type, preferred oral anticoagulant, duration of triple oral antithrombotic therapy, and choice of antiplatelet agent to discontinue)
This survey demonstrates significant diversity in clinical approaches to antithrombotic therapy for AF patients undergoing PCI, highlighting a growing interest in dropping aspirin but underscoring the need for definitive clinical trial data.
Cite This Study
Vardi et al. (2013) studied this question.